Complement Activation & Thrombotic Microangiopathy Associated with AAV Gene Therapy

Time: 1:30 pm
day: Day Two

Details:

  • Overview of the complement system and complementopathies
  • Thrombotic microangiopathy (TMA) associated with AAV gene therapy: atypical hemolytic-uremic syndrome (aHUS)
  • Case characteristics of AAV-associated TMA/aHUS
  • Surveillance, diagnosis and management

Speakers: